Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 27, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
DRL filed a 6-K, just routine paperwork, no big news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 27, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events beyond its routine reporting nature.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is fulfilling its ongoing reporting obligations as a foreign private issuer with the SEC.
Risk Assessment
Risk Level: low — This filing is a standard procedural report and does not contain new material information that would typically impact stock price.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer of the report
- 0001575872-24-001035 (accession_number) — Unique identifier for the filing
- 20240927 (date) — Filing date and period of report
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used by Dr. Reddy's Laboratories Ltd. to submit information to the SEC.
What is the filing date of this report?
The filing date is September 27, 2024.
Is Dr. Reddy's Laboratories Ltd. filing an annual report under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does this filing contain specific financial results or material events?
Based on the provided text, this Form 6-K appears to be a routine filing and does not detail specific financial results or new material events.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-27 12:35:34
Filing Documents
- drr0675_6k.htm (6-K) — 13KB
- drr0675_ex99-1.htm (EX-99.1) — 22KB
- drr0675_ex99-1img01.jpg (GRAPHIC) — 7KB
- drr0675_ex99-1img02.jpg (GRAPHIC) — 8KB
- drr0675_ex99-1img03.jpg (GRAPHIC) — 9KB
- drr0675_ex99-1img04.jpg (GRAPHIC) — 8KB
- 0001575872-24-001035.txt ( ) — 81KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 27, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3